Widely used:Recently Viewed
Clear All
Value Research Rating
Quality Score 
7/10
Growth Score
6/10
Valuation Score
3/10
Momentum Score
10/10
₹13,272 Cr
26.97
3.97
45.71
0.02
15.89 %
--
0.27 %
137.88
20
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Granules India
| 35.02 | -17.35 | 18.56 | 65.27 | 18.64 | 39.33 | 22.37 |
|
BSE Healthcare
| 38.71 | 6.31 | 17.31 | 52.58 | 18.12 | 27.78 | 12.31 |
|
BSE Mid Cap
| 32.62 | 3.09 | 6.08 | 50.30 | 24.95 | 29.55 | 17.57 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Granules India
| 27.18 | -5.18 | -6.43 | 188.88 | 35.57 | -34.70 | 27.21 |
|
BSE Mid Cap
| 45.53 | 1.38 | 39.18 | 19.87 | -3.05 | -13.31 | 48.13 |
|
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
loading... |
|||
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Our rating system has guided millions of investors in the past 20 years.
₹13,272.11 Cr
₹4,700.72 Cr
₹492.06 Cr
₹386.39 Cr
₹1,223.23 Cr
38.87%
High
₹318.95 - 721.00
₹1.00
24,23,68,716
NSE: GRANULES, BSE: 532482
Hyderabad, Telangana
www.granulesindia.com
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally.... The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India. Read more
The total asset value of Granules India Ltd stood at ₹ 5,521 Cr as on 30-Jun-24
The share price of Granules India Ltd is ₹547.45 (NSE) and ₹547.60 (BSE) as of 18-Sep-2024 IST. Granules India Ltd has given a return of 18.64% in the last 3 years.
Granules India Ltd has a market capitalisation of ₹ 13,272 Cr as on 18-Sep-2024. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Granules India Ltd is 3.97 times as on 18-Sep-2024, a 16% discount to its peers’ median range of 4.73 times.
The P/E ratio of Granules India Ltd is 26.97 times as on 18-Sep-2024, a 41% discount to its peers’ median range of 45.71 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Granules India Ltd and enter the required number of quantities and click on buy to purchase the shares of Granules India Ltd.
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.
The promoters of Granules India Ltd are KRISHNA PRASAD CHIGURUPATI and CHIGURUPATI UMA DEVI. They collectively own 35.5 per cent of the total equity. The chairman of the company is Krishna Prasad Chigurupati
There is no promoter pledging in Granules India Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
49,449
|
|
|
37,204
|
|
|
30,717
|
|
|
30,154
|
| Granules India Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
15.89
|
|
Operating margin(%)
|
16.33
|
|
Net Margin(%)
|
10.45
|
|
Dividend yield(%)
|
0.27
|
Yes, TTM profit after tax of Granules India Ltd was ₹492 Cr.
₹3.25
